González L, Collazo T, Clark Y, Gómez M, Reyes L

Language: Spanish
References: 12
Page: 257-261
PDF size: 344.88 Kb.

ABSTRACT

Cystic fibrosis is an autosomal recessive disease. Its incidence in Cuba is 1 in 5000 live births. The molecular cause underlying this disease is related to mutations in the regulatory gene encoding the cystic fibrosis transmembrane regulator (CFTR). In this study, the techniques for the study of IVS17bTA microsatellite marker were standardized, and the most frequent mutations in the CFTR gene were also detected for 21 Cuban families. Polymerase chain reaction, agarose and polyacrylamide (plus silver staining) gel electrophoresis techniques were used for both, identification of mutations and microsatellite standardization. Among the 22 Cuban patients, seven were found homozygous, four compound heterozygous and 11 with a single mutation so, 33 chromosomes were molecularly characterized for the 75 %. Twelve allelic variants were found for the IVS17bTA microsatellite; alleles 31 and 7 the most frequent ones. Alleles 31 and 46 were associated to the F508del and R334W mutations, respectively. Among the 21 families, 18 were completely informative for the IVS17bTA microsatellite marker, accounting for 85.7 %. This study helped to complete the diagnosis in those patients in which the responsible mutations in one or both chromosomes had not yet been identified. Besides, we were also able to identify mutations associated with different alleles of the marker without gene sequencing, also helping to decrease the cost of screening.

REFERENCES

1. Collazo T, Piloto Y, Clark Y, Boffi l AM, Gómez M, Hernández Y. Detección de mutaciones en pacientes cubanos con fi brosis quística. Biotecnol Apl. 2008;25(4): 345-9.

2. Scriver CR, Beaudet AL, Sly GW, Valle D, editors. The metabolic and molecular bases of inherited diseases. 7th ed. Vol. 3. New York; Mc Graw-Hill; 1995.

3. Cystic Fibrosis Mutation Database (CFMDB) [Internet]. Ontario: Cystic Fibrosis Consortium. c2011 [cited 2013 Aug 9]; Available from: http://www.genet.sickkids. on.ca/cftr/StatisticsPage.html

4. Collazo T, Bofi ll AM, Clark Y, Hernandez Y, Gomez M, Rodriguez F, et al. Common mutations in Cuban cystic fi brosis patients. J Cyst Fibros. 2009;8(1):47-9.

5. Collazo T, López I, González L, Clark Y, Piloto Y, Gómez M, et al. Estudio molecular de la fi brosis quística en Cuba. In: Memorias Convención Internacional de Salud Pública. Cuba Salud 2012. La Habana 3-7 de diciembre de 2012, Cuba. La Habana: Ministerio de Salud Pública; 2002.

6. Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet. 1989;44(3):388-96.

7. Estivill X, Morral N, Casals T, Nunes V. Prenatal diagnosis of cystic fi brosis by multiplex PCR of mutation and microsatellite alleles. Lancet. 1991;338(8764):458.

8. Visich AA, Barreiro CZ, Chertkoff LP. Caracterización de tres microsatélites del gen de fi brosis quística en familias argentinas. Medicina (Buenos Aires). 2001; 61(1):23-7.

9. Zielenski J, Rozmahel R, Bozon D, Kerem B, Grzelczak Z, Riordan JR, et al. Genomic DNA sequence of the cystic fi brosis transmembrane conductance regulator (CFTR) gene. Genomics. 1991;10(1): 214-28.

10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215-8.

11. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplifi cation refractory mutation system (ARMS). Nucleic Acids Res. 1989;17(7):2503-16.

12. Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, Gimenez J, et al. The origin of the major cystic fi brosis mutation (delta F508) in European populations. Nat Genet. 1994;7(2):169-75.